Suggested markers for the diagnosis of endometriosis

Current Women's Health Reviews

Volumn 4, Issue 1, 2008, Pages 25-28

  Matalliotakis, Ioannis M ^a   Vassiliadis, Simon ^a   Goumenou, Anastasia G ^a   Fragouli, Yvoni ^b   Athanassakis, Irene ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Cytokines; Endometriosis; IFN ; IL 12; IL 15; IL 18; VEGF

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; GAMMA INTERFERON; HLA A24 ANTIGEN; HLA B ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; HLA DR5 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 8 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIGEN EXPRESSION; CULDOSCOPY; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE MARKER; ENDOMETRIOSIS; ENDOMETRIUM CELL; HLA TYPING; HUMAN; HYPOTHESIS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOREGULATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 47749120013     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340408783572042     Document Type: Review

References (35)

1. Simpson JL, Elias S, Malinak LR, Buttram VC. Heritable aspects of endometriosis. I. Genetic Studies. Am J Obstet Gynecol 1980; 137: 327-31.
2. Panidis DK, Matalliotakis IM. Subfertility associated with minimal to mild endometriosis. Main Mechanisms. J Reprod Med 1998; 42: 1034-42.
3. Arici A, Tazuke IS, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996; 2: 40-5.
4. Kennedy S, Mardon H, Barlow D. Familial endometriosis. J Assist Reprod Genet 1995; 12: 32-4.
5. Koninckx TK, Kennedy SH, Barlow DH. Endometriotic disease: The role of peritoneal fluid, Human Reprod. Update 1998; 4: 741-51.
6. Wu MH, Yang BC, Hsu CC, Lee YC, Huang KE. The expression of soluble intracellular adhesion molecule-1 in endometriosis. Fert Steril 1998; 70: 1139-42.
7. Senturk L, Arici, A. Immunology of endometriosis. J Reprod Immunol 1998; 43: 67-83.
8. Olive D, Weinberg J, Haney A. Peritoneal macrophages and infertility: the association between cell number and pelvic pathology. Fertil Steril 1985; 44: 772-7.
9. Arici A, Oral E, Attar E, Tazuke SI, Olive DL. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril 1997; 67: 1065-72.
10. Halme J, White C, Kauma S, Estes J, Haskill S. Peritoneal macrphages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metab 1988; 66: 1044-9.
11. Oosterlynck D, Meuleman C, Waer M, Koninckx P. Transforming growth factor-beta activity is increased in peritoneal fluid from women with endometriosis. Obstet Gynecol 1994; 83: 287-32.
12. Garcia-Velasco J, Arici A. Chemokines and human reproduction. Fertil Steril 1999; 71: 983-93.
13. Rier S, Parsons A, Becker J. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril 1994; 61: 294-9.
14. Arici A, Tazuke SI, Attar E, Kliman HJ, Olive DL. Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells. Mol Hum Reprod 1996; 2: 40-5.
15. Oral E, Olive D, Arici A. The peritoneal environment in endometriosis. Hum Reprod Update 1996; 2: 385-98.
16. D'Hooge T, Xiao L, Hill J. Cytokine profiles in autologous peritoneal fluid and peripheral blood of women with deep and superficial endometriosis. Arch Gynecol Obstet 2001; 265: 40-4.
17. Vassiliadis S, Relakis K, Papageorgiou A, Athanassakis I. Endometriosis and infertility: A multi-cytokine imbalance versus ovulation, fertilization and early embryo development. Clin Devel Immunol 2005; 12: 125-9.
18. Luk J, Seval Y, Kayisli UA, Ulukus M, Ulukus CE, Arici A. Regulation of interleukin-8 expression in human endometrial endothelial cells: a potential mechanism for the pathogenesis of endometriosis. J Clin Endocritiol Metab 2005; 90:1805-11.
19. Bersinger NA, von Roten S, Wunder DM, Raio L, Dreher E, Mueller MD. PAPP-A and osteoprotegerin, together with interleukin-8 and RANTES, are elevated in the peritoneal fluid of women with endometriosis. Am J Obstet Gynecol 2006; 195: 103-8.
20. Wieser F, Dogan S, Klingel K, Diedrich K, Taylor RN, Hornung D. Expression and regulation of CCR1 in peritoneal macrophages from women with and without endometriosis. Fertil Steril 2005; 83:1878-81.
21. Antinolo G, Fernandez RM, Noval JA, Molini JL, Borrego S. Analysis of the involvement of CCR5-Delta32 and CCR2-V64I variants in the development of endometriosis. Mol Hum Reprod 2004; 10:155-7.
22. Matalliotakis IM, Goumenou AG, Koumantakis GE, et al, Serum concentrations of growth factors in women with endometriosis: The action of anti-endometriosis medicines. Intl Immunopharmacol 2003; 3: 81-9.
23. Matalliotakis I, Goumenou AG, Koumantakis GE, et al. Expression of serum human leukocyte antigen (HLA) and growth factor (VEGF and EGF-Rc) levels in a Greek case of familial endometriosis. J Soc Gynecol Invest 2003; 10: 118-121.
24. Matalliotakis I, Vassiliadis S, Goumenou A, et al. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. J Reprod Immunol 2001; 51: 9-19.
25. Arici A, Matalliotakis I, Goumenou A, et al. Increased levels of interleukin-15 in the peritoneal fluid of women with endometriosis: Inverse correlation with stage and depth of invasion. Human Reprod 2003; 18: 429-32.
26. Arici A, Matalliotakis I, Goumenou A, Koumantakis G, Vassiliadis S, Mahutte NG. Altered expression of Interleukin-18 in the peritoneal fluid of women with endometriosis. Fertil Steril 2003; 80:889-94.
27. Simpson JL, Malinak LR, Elias S, Carson SA, Radvany RA. HLA association in endometriosis. Am J Obstet Gynecol 1984; 148: 395-7.
28. Moen M, Bratlie A, Moen T. Distribution of HLA-antigens among patient with endometriosis. Acta Obstel Gynecol Scand Suppl 1984; 123: 25-7.
29. McDonald JC, Adamashvili I. Soluble HLA: A review of the literature. Hum Immunol 1998; 59: 387-403.
30. Matalliotakis I, Athanassakis I, Neonaki M, Goumenou A, Vassiliadis S, Koumantakis E. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot. Med Inflamm 2001; 10: 75-80.
31. Kao KJ. Plasma and platelet HLA in normal individuals: Quantitation by competitive enzyme-linked immunoassay. Blood 1987; 70: 282-6.
32. Zavazava N, Westphal E, Muller-Ruchholtz W. Characterization of soluble HLA molecules in swet and quantitative HLA differences in serum of healthy individuals. J Immunogenet 1990; 17: 387-94.
33. Weyand CM, Jendro M, Goronzy JJ. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 1991; 8: 281-7.
34. Hagihara M, Shimura T, Yamamoto K, Takebe K, Munkhbat B, Tsuji K. Soluble HLA class I and class II in Japanese. Hum Immunol 1994; 40: 171-3.
35. H2 cytokines and soluble MHC molecules: A paradigm in pregnancy. Immunology 2002; 107: 281-7.